Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Medtronic
McKinsey
Johnson and Johnson
Moodys

Last Updated: December 7, 2021

DrugPatentWatch Database Preview

Patent: 8,470,775

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 8,470,775
Title:Compositions and methods for reducing the risk of preeclampsia
Abstract: Methods and kits for preventing or reducing the likelihood of implantation failure or miscarriage in a recipient of artificial insemination are provided. The methods include administering into a recipient of artificial insemination in need of such treatment an effective amount of granulocyte colony stimulating factor (G-CSF).
Inventor(s): Carter; Darryl L. (Owings Mills, MD)
Assignee: Nora Therapeutics, Inc. (Palo Alto, CA)
Application Number:13/326,866
Patent Claims:see list of patent claims

Details for Patent 8,470,775

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Amgen, Inc. NEUPOGEN filgrastim Injection 103353 1991-02-20 ⤷  Try it Free 2023-10-24
Amgen, Inc. NEUPOGEN filgrastim Injection 103353 2000-06-28 ⤷  Try it Free 2023-10-24
Amgen, Inc. NEULASTA pegfilgrastim Injection 125031 2002-01-31 ⤷  Try it Free 2023-10-24
Amgen, Inc. NEULASTA ONPRO pegfilgrastim Injection 125031 2014-12-23 ⤷  Try it Free 2023-10-24
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Baxter
Medtronic
Moodys
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.